Pebble Labs
Santa Fe, US · Founded 2019 · Delaware corporation · 15 employees on LinkedIn · 1 known investors
Pebble Labs develops Directed Biotics technology, using microbes and RNA interference-based molecules to activate defense mechanisms in host crops. The company applies computational biology and bioinformatics to agricultural applications such as crop protection.
Founders & leadership
Pebble Labs was founded in 2019 by Richard Thomas Sayre.
RT
Richard Thomas SayreFounder
KS
Kelly SchillingChief Operating Officer
JS
Johnny SenaChief Scientific Officer
MB
Michael Bruce HarrisonNamed on SEC filing
JM
Jon M. BloodworthNamed on SEC filing
ET
Edward T. L. CheungNamed on SEC filing
DS
David SmalleyNamed on SEC filing
RE
Ronald E. DeutschNamed on SEC filing
KA
Kimberly A. LandryNamed on SEC filing
RT
Richard T. DeRoseNamed on SEC filing
AL
Aristobulo LoaizaNamed on SEC filing
TR
Tichafa R. I. MunyikwaNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.5M disclosed across 2 rounds · 2019
▶$3MraisedSep 2019 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SmalleyExecutive Officer, Director, Promoter
- Ronald E. DeutschExecutive Officer
- Kimberly A. LandryExecutive Officer, Promoter
- Richard T. DeRoseExecutive Officer
- Aristobulo LoaizaExecutive Officer
- Tichafa R. I. MunyikwaExecutive Officer
- Anne LoExecutive Officer
- Paul M. LaurExecutive Officer
- Andrew T. HunterExecutive Officer
- Pedro Costa-NunesExecutive Officer
- Tatiana VinogradovaExecutive Officer
- Edward T. L. CheungExecutive Officer, Promoter
- Jon M. BloodworthExecutive Officer
- Tawanda ZidengaExecutive Officer
- Erick LeBrunExecutive Officer
- Michael Bruce HarrisonExecutive Officer, Director, Promoter
- Richard Thomas SayreExecutive Officer, Promoter
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$9.5MraisedSep 2019 · 4 investors · BiotechnologyRule 506(b)
▶$9.5MraisedSep 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael Bruce HarrisonExecutive Officer, Director, Promoter
- Jon M. BloodworthExecutive Officer
- Edward T. L. CheungExecutive Officer, Promoter
- Richard Thomas SayreExecutive Officer, Promoter
- David SmalleyExecutive Officer, Director, Promoter
- Ronald E. DeutschExecutive Officer
- Kimberly A. LandryExecutive Officer, Promoter
- Richard T. DeRoseExecutive Officer
- Aristobulo LoaizaExecutive Officer
- Tichafa R. I. MunyikwaExecutive Officer
- Anne LoExecutive Officer
- Paul M. LaurExecutive Officer
- Andrew T. HunterExecutive Officer
- Pedro Costa-NunesExecutive Officer
- Tatiana VinogradovaExecutive Officer
- Tawanda ZidengaExecutive Officer
- Erick LeBrunExecutive Officer
- Offering amount
- $9.5M
- Amount sold
- $9.5M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Pebble Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pebble Labs do?
- Pebble Labs develops Directed Biotics technology, using microbes and RNA interference-based molecules to activate defense mechanisms in host crops. The company applies computational biology and bioinformatics to agricultural applications such as crop protection.
- Who founded Pebble Labs?
- Pebble Labs was founded by Richard Thomas Sayre in 2019.
- Who are Pebble Labs's investors?
- Pebble Labs's investors include Gotham Green Partners.
- How much funding has Pebble Labs raised?
- Pebble Labs has disclosed $12.5M raised across 2 rounds.
- Where is Pebble Labs headquartered?
- Pebble Labs is headquartered in Santa Fe, US.